<i>HNF4A</i> and <i>GATA6</i> Loss Reveals Therapeutically Actionable Subtypes in Pancreatic Cancer
Author(s) -
Holly Brunton,
Giuseppina Caligiuri,
Richard Cunningham,
Rosanna UpstillGoddard,
UllaMaja Bailey,
Ian Garner,
Craig Nourse,
Stephan Dreyer,
Marc D. Jones,
Kim MoranJones,
Derek Wright,
Viola Paulus-Hock,
Colin Nixon,
Gemma Thomson,
Nigel B. Jamieson,
Grant A. McGregor,
Lisa Evers,
Colin J. McKay,
Aditi Gulati,
Rachel Brough,
Ilirjana Bajrami,
Stephen Pettit,
Michele Dziubinski,
Simon T. Barry,
Robert Grützmann,
Robert Brown,
Edward Curry,
Glasgow Precision Oncology Laboratory,
Australian Pancreatic Cancer Genome Initiative,
Marina Pajic,
Elizabeth A. Musgrove,
Gloria Petersen,
Emma Shanks,
Alan Ashworth,
Howard C. Crawford,
Diane M. Simeone,
Fieke E. M. Froeling,
Christopher J. Lord,
Debabrata Mukhopadhyay,
Christian Pilarsky,
Sean E. Grimmond,
Jennifer P. Morton,
Owen J. Sansom,
David K. Chang,
Peter J. Bailey,
Andrew V. Biankin
Publication year - 2019
Publication title -
ssrn electronic journal
Language(s) - English
Resource type - Journals
ISSN - 1556-5068
DOI - 10.2139/ssrn.3430714
Subject(s) - gata6 , cancer research , pancreatic cancer , medicine , chemistry , cancer , transcription factor , biochemistry , gene
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom